KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for UiPath (PATH) over the last 5 years, with Q4 2025 value amounting to $743.7 million.

  • UiPath's Cash & Equivalents fell 387.39% to $743.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $743.7 million, marking a year-over-year decrease of 387.39%. This contributed to the annual value of $879.2 million for FY2025, which is 1718.81% down from last year.
  • As of Q4 2025, UiPath's Cash & Equivalents stood at $743.7 million, which was down 387.39% from $628.6 million recorded in Q3 2025.
  • UiPath's Cash & Equivalents' 5-year high stood at $1.8 billion during Q3 2021, with a 5-year trough of $357.7 million in Q1 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $1.1 billion (2023), whereas its average is $1.2 billion.
  • As far as peak fluctuations go, UiPath's Cash & Equivalents skyrocketed by 39448.49% in 2022, and later plummeted by 3889.5% in 2025.
  • Quarter analysis of 5 years shows UiPath's Cash & Equivalents stood at $1.8 billion in 2021, then dropped by 18.31% to $1.5 billion in 2022, then plummeted by 30.88% to $1.0 billion in 2023, then fell by 22.87% to $773.6 million in 2024, then fell by 3.87% to $743.7 million in 2025.
  • Its Cash & Equivalents stands at $743.7 million for Q4 2025, versus $628.6 million for Q3 2025 and $700.6 million for Q2 2025.